Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dermatology

  Free Subscription


20.11.2017

4 Am J Dermatopathol
1 BMC Cancer
25 Br J Dermatol
1 Cancer Res
4 Cutis
1 Eur J Dermatol
1 Int J Cancer
2 Int J Dermatol
1 J Cutan Pathol
2 J Dermatol
3 J Invest Dermatol
2 Plast Reconstr Surg
1 PLoS Comput Biol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. GARCIA-DE-LA-FUENTE MR, Santacana M, Valls J, Vilardell F, et al
    Cytokeratin Profile of Basal Cell Carcinomas According to the Degree of Sun Exposure and to the Anatomical Localization.
    Am J Dermatopathol. 2017 Nov 1. doi: 10.1097/DAD.0000000000001042.
    PubMed     Text format     Abstract available

  2. BELOUSOVA IE, Khairutdinov VR, Bessalova A, Kazakov DV, et al
    Mycosis Fungoides Manifesting as Giant Cell Lichenoid Dermatitis.
    Am J Dermatopathol. 2017 Nov 10. doi: 10.1097/DAD.0000000000001032.
    PubMed     Text format     Abstract available

  3. REQUENA C, Rubio L, Lavernia J, Machado I, et al
    Immunohistochemical and Fluorescence In Situ Hybridization Analysis of MYC in a Series of 17 Cutaneous Angiosarcomas: A Single-Center Study.
    Am J Dermatopathol. 2017 Nov 7. doi: 10.1097/DAD.0000000000001053.
    PubMed     Text format     Abstract available

  4. CLARK ML, McGuinness AE, Vidal CI
    Cutaneous Collagenous Vasculopathy: A Unique Case With Positive Direct Immunofluorescence Findings.
    Am J Dermatopathol. 2017 Oct 24. doi: 10.1097/DAD.0000000000001041.
    PubMed     Text format    


    BMC Cancer

  5. CIRILO PDR, de Sousa Andrade LN, Correa BRS, Qiao M, et al
    MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1.
    BMC Cancer. 2017;17:750.
    PubMed     Text format     Abstract available


    Br J Dermatol

  6. FINLAY AY
    Every dermatology consultation: think adherence.
    Br J Dermatol. 2017;176:558-559.
    PubMed     Text format    

  7. STRAZZULLA LC, Avila L, Lo Sicco K, Shapiro J, et al
    Response to 'Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens'.
    Br J Dermatol. 2017;177:323.
    PubMed     Text format    

  8. MAHER NG, Guitera P
    Imiquimod treatment for lentigo maligna: LIMIT-1 trial.
    Br J Dermatol. 2017;177:324-325.
    PubMed     Text format    

  9. WHITE IR
    Quantitative risk assessment and the burden of fragrance contact allergy.
    Br J Dermatol. 2017;176:860-861.
    PubMed     Text format    

  10. MAKRYGEORGOU A
    Secukinumab shows reassuring low immunogenicity.
    Br J Dermatol. 2017;176:573-574.
    PubMed     Text format    

  11. DING S, Chen J, Zeng Q, Lu J, et al
    Chronic sun exposure is associated with distinct histone acetylation changes in human skin.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16129.
    PubMed     Text format     Abstract available

  12. KANG EG, Wu S, Gupta A, von Mackensen YL, et al
    A Phase I Randomised Controlled Trial to Evaluate Safety and Clinical Effect of Topically Applied GSK2981278 Ointment in a Psoriasis Plaque Test.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16131.
    PubMed     Text format     Abstract available

  13. VASSEUR P, Pohin M, Jegou JF, Favot L, et al
    Liver fibrosis is associated with cutaneous inflammation in the imiquimod-induced murine model of psoriasiform dermatitis.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16137.
    PubMed     Text format     Abstract available

  14. MARONAS-JIMENEZ L, Estrach T, Gallardo F, Perez A, et al
    Aprepitant improves refractory pruritus in primary cutaneous T-cell lymphomas: experience of the Spanish Working Group on Cutaneous Lymphomas.
    Br J Dermatol. 2017 Nov 18. doi: 10.1111/bjd.16128.
    PubMed     Text format     Abstract available

  15. WINSLOW UC, Nordestgaard BG, Afzal S
    High plasma 25-hydroxyvitamin D and high risk of non-melanoma skin cancer: a Mendelian randomisation study of 97849 individuals.
    Br J Dermatol. 2017 Nov 16. doi: 10.1111/bjd.16127.
    PubMed     Text format     Abstract available

  16. STOFFEL E, Maier H, Riedl E, Bruggen MC, et al
    Analysis of anti-TNF-induced skin lesions reveals strong Th1 activation with some distinct immunological characteristics.
    Br J Dermatol. 2017 Nov 16. doi: 10.1111/bjd.16126.
    PubMed     Text format     Abstract available

  17. STOODLEY P
    Evidence for a biofilm-based treatment strategy in the management of chronic hidradenitis suppurativa.
    Br J Dermatol. 2017;176:855-856.
    PubMed     Text format    

  18. HAMPTON P, Meggitt S
    Better definition of hidradenitis suppurativa subtypes is needed to progress disease-specific treatment outcomes.
    Br J Dermatol. 2017;176:862-863.
    PubMed     Text format    

  19. CHU CY
    Measuring quality of life in infants, children and adolescents with eczema.
    Br J Dermatol. 2017;176:848-849.
    PubMed     Text format    

  20. CUST AE
    Estimating the future health service burden of keratinocyte cancers in the U.K.
    Br J Dermatol. 2017;176:1107-1108.
    PubMed     Text format    

  21. HASHIMOTO T, Mizoguchi A
    Interleukin-10-producing B-cells in autoimmune bullous diseases.
    Br J Dermatol. 2017;176:1119-1120.
    PubMed     Text format    

  22. WILKIN J
    Updating the diagnosis, classification and assessment of rosacea by effacement of subtypes.
    Br J Dermatol. 2017;177:597-598.
    PubMed     Text format    

  23. GELLER S, Sprecher E
    IgA pemphigus: lumping or splitting?
    Br J Dermatol. 2017;177:581-582.
    PubMed     Text format    

  24. BRUNASSO AMG, Massone C
    Alitretinoin therapy for palmoplantar pustulosis.
    Br J Dermatol. 2017;177:578-579.
    PubMed     Text format    

  25. THOMPSON AR, Bewley AP
    Meeting the psychological needs of dermatology patients.
    Br J Dermatol. 2017;176:858-859.
    PubMed     Text format    

  26. OFENLOCH RF
    Health-related quality of life in hidradenitis suppurativa.
    Br J Dermatol. 2017;176:861-862.
    PubMed     Text format    

  27. AGNER T, Nixon R
    Hand eczema is to be taken seriously ....
    Br J Dermatol. 2017;176:854-855.
    PubMed     Text format    

  28. BROWN SJ
    Evidence-based medicine for atopic eczema: identifying the knowns and unknowns.
    Br J Dermatol. 2017;176:842-844.
    PubMed     Text format    

  29. SCHREML S, Berneburg M
    The global burden of diabetic wounds.
    Br J Dermatol. 2017;176:845-846.
    PubMed     Text format    

  30. IBBOTSON SH
    Shedding light on drug photosensitivity reactions.
    Br J Dermatol. 2017;176:850-851.
    PubMed     Text format    


    Cancer Res

  31. MO X, Zhang H, Preston S, Martin K, et al
    Interferon-2; signaling in melanocytes and melanoma cells regulates expression of CTLA-4.
    Cancer Res. 2017 Nov 17. pii: canres.1615.2017.
    PubMed     Text format     Abstract available


    Cutis

  32. ALLAN A, Altman DA, Su W
    Granulomatous pigmented purpuric dermatosis.
    Cutis. 2017;100:256-258.
    PubMed     Text format     Abstract available

  33. WILKISON BD, Wong EB
    Skin cancer in military pilots: a special population with special risk factors.
    Cutis. 2017;100:218-220.
    PubMed     Text format     Abstract available

  34. KAILAS A, Botwin AL, Pritchett EN, Jackson-Richards D, et al
    Assessing the effectiveness of knowledge-based interventions in increasing skin cancer awareness, knowledge, and protective behaviors in skin of color populations.
    Cutis. 2017;100:235-240.
    PubMed     Text format     Abstract available

  35. COHEN PR
    Do infants fed rice and rice products have an increased risk for skin cancer?
    Cutis. 2017;100:250.
    PubMed     Text format    


    Eur J Dermatol

  36. SMETS K, Busschots A, Hauben E, Goossens A, et al
    B-cell lymphomatoid contact dermatitis caused by methylisothiazolinone and methylchloroisothiazolinone.
    Eur J Dermatol. 2017 Nov 15. doi: 10.1684/ejd.2017.3156.
    PubMed     Text format    


    Int J Cancer

  37. KAWADA T
    Prognosis of sentinel lymph node biopsy in patients with thick melanoma by a propensity score matching prospective study.
    Int J Cancer. 2017 Nov 18. doi: 10.1002/ijc.31163.
    PubMed     Text format    


    Int J Dermatol

  38. SHAH K, Mehmood S, Jan A, Abbe I, et al
    Sequence variants in nine different genes underlying rare skin disorders in 10 consanguineous families.
    Int J Dermatol. 2017;56:1406-1413.
    PubMed     Text format     Abstract available

  39. LOPES S, Baudrier T, Azevedo F
    Flat-topped papules arising in a young woman's tattoo.
    Int J Dermatol. 2017 Nov 11. doi: 10.1111/ijd.13826.
    PubMed     Text format    


    J Cutan Pathol

  40. RUSH PS, Rosenbaum JN, Roy M, Baus RM, et al
    INSM1: A Novel Nuclear Marker in Merkel Cell Carcinoma (Cutaneous Neuroendocrine Carcinoma).
    J Cutan Pathol. 2017 Nov 17. doi: 10.1111/cup.13079.
    PubMed     Text format     Abstract available


    J Dermatol

  41. ICHIYAMA S, Hoashi T, Funasaka Y, Mikami E, et al
    Pigmented poroma on the temporal region dermoscopically mimicking basal cell carcinoma: A report of two cases.
    J Dermatol. 2017 Nov 15. doi: 10.1111/1346-8138.14129.
    PubMed     Text format    

  42. WEI W, Anderson P, Gadkari A, Blackburn S, et al
    Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis.
    J Dermatol. 2017 Nov 13. doi: 10.1111/1346-8138.14116.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  43. FANOK MH, Sun A, Fogli LK, Narendran V, et al
    Role of dysregulated cytokine signaling and bacterial triggers in the pathogenesis of Cutaneous T Cell Lymphoma.
    J Invest Dermatol. 2017 Nov 8. pii: S0022-202X(17)33144.
    PubMed     Text format     Abstract available

  44. FUHRIMAN JM, Winge MCG, Haberstock-Debic H, Funk JO, et al
    ITK and RLK inhibitor PRN694 improves skin disease in two mouse models of psoriasis.
    J Invest Dermatol. 2017 Nov 9. pii: S0022-202X(17)33145.
    PubMed     Text format     Abstract available

  45. KIM TG, Kim SH, Park J, Choi W, et al
    Skin-Specific CD301b+ Dermal Dendritic Cells Drive IL-17-Mediated Psoriasis-Like Immune Response in Mice.
    J Invest Dermatol. 2017 Nov 11. pii: S0022-202X(17)33152.
    PubMed     Text format     Abstract available


    Plast Reconstr Surg

  46. FRACOL M, Grim M, Lanier S, Fine NA, et al
    Vertical Skin Paddle Orientation for the Latissimus Dorsi Flap in Breast Reconstruction: A Modification to Simultaneously Correct Inferior Pole Constriction and Improve Projection.
    Plast Reconstr Surg. 2017 Nov 8. doi: 10.1097/PRS.0000000000004103.
    PubMed     Text format     Abstract available

  47. NUUTILA K, Laukkanen A, Lindford A, Juteau S, et al
    Inhibition of Skin Wound Contraction by Nanofibrillar Cellulose Hydrogel.
    Plast Reconstr Surg. 2017 Nov 8. doi: 10.1097/PRS.0000000000004168.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  48. ROMAN T, Xie L, Schwartz R
    Automated deconvolution of structured mixtures from heterogeneous tumor genomic data.
    PLoS Comput Biol. 2017;13:e1005815.
    PubMed     Text format     Abstract available


    PLoS One

  49. CARLSEN JF, Ewertsen C, Sletting S, Talman ML, et al
    Strain histograms are equal to strain ratios in predicting malignancy in breast tumours.
    PLoS One. 2017;12:e0186230.
    PubMed     Text format     Abstract available

  50. SHIBATA A, Kuno M, Adachi R, Sato Y, et al
    Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy.
    PLoS One. 2017;12:e0186587.
    PubMed     Text format     Abstract available

  51. BRUNNER MAT, Jagannathan V, Waluk DP, Roosje P, et al
    Novel insights into the pathways regulating the canine hair cycle and their deregulation in alopecia X.
    PLoS One. 2017;12:e0186469.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: